CAS: 98106-17-3; 6-Fluoro-1-(4-Fluorophenyl)-7-(4-Methylpiperazin-1-yl)-4-Oxo-1,4-Dihydroquinoline-3-Carboxylic Acid

该化合物是主要用于分析和制药研究的高纯度参考材料,是质量控制的关键基准,确保各种样品中二氟氯辛的准确量化和识别,其特点是化学稳定性异常,成分精确,杂质水平低,适合六氯丙烯,长效环十二烷和其他色谱学应用,其一贯性能支持方法验证,监管合规和研究再生.二氟氯辛标准具备全面认证,包括详细的分析数据,符合药典标准的严格要求(如美国专利局,欧洲专利局).这一产品对于需要可靠的抗生素分析和残留试验参考材料的实验室至关重要.

结构式图片

上下游产品

CAS号704-10-9 2,4-二氯-5-氟苯乙酮 | CAS号86483-51-4 2,4-二氯-5-氟-Β-氧代苯丙酸乙酯 | CAS号86483-52-5 2-(2,4-二氯-5-氟苯甲... | CAS号109-01-3 N-甲基哌嗪 | CAS号98105-79-4 7-氯-6-氟-1-对氟苯基-... | CAS号98349-24-7 2,4,5-三氟苯甲酰乙酸乙酯 | CAS号108138-16-5 1-(p-fluorophen...

合成工艺路线路线简述

  • 合成目标产物 Difloxacin 主要起始原料 2,4-Dichloro-5-Fluoroacetophenone
  • (文献来源)合成步骤主要原料 2,4-Dichloro-5-Fluoroacetophenone
2,4,5-三氟苯甲酰乙酸乙酯置于盐酸,水,乙酸酐,Sodium Hydride,溶剂黄146,三乙胺体系中,用 四氢呋喃,二氯甲烷,乙腈,Mineral Oil 作为反应溶剂,化学反应生成 双氟沙星
参考文献:Synthesis Of [1-15N,2-13C]-Labeled Difloxacin
标题:Synthesis Of [1-15N,2-13C]-Labeled Difloxacin
摘要:The Synthesis Of [1-N-15,2-C-13]-Difloxacin,An Arylfluoroquinolone Antibacterial Agent,Is Reported. As A Crucial Initial Step,The Starting Materials Ethyl 2,4,5-Trifluorobenzoylacetate,[formyl-C-13]-Triethyl Orthoformate,And [n-15]-4-Fluoroaniline Were Reacted To Ethyl [n-15,3-C-13]-3-(4-Fluoroanilino)-2-(2,4,5-Trifluorobenzoyl) Acrylate. After Cyclization And Ester Cleavage,The Resulting Intermediate Was Reacted With 1-Methylpiperazine To [1-N-15,2-C-13]-1-(4-Fluorophenyl)-6-Fluoro-7-(4-Methyl-1-Piperazinyl)-1,4-Dihydro-4-Oxoquinoline-3-Carboxylate,I.E.,[1-N-15,2-C-13]-Difloxacin. The Overall Yield Was 62% Based On The Non-Labeled And 43% Based On The Labeled Starting Materials (Both Used In 1.4 Molar Excess). The Product Was Identified By H-1-,C-13-,And N-15-NMR Spectroscopy And By Cochromatography (Tlc,HPLC) With An Authentic Reference; Its Purity (HPLC) Was Above 98%. Prior To Synthesis Of [1-N-15,2-C-13]-Difloxacin,Non-Labeled Difloxacin Was Synthesized In Order To Optimize Procedures And To Identify And Characterize All Intermediates.
DOI:10.1007/s00706-009-0158-Y

海关参考信息

专利信息


专利号:US-11332444-B2
优先权日:2018-04-25
标题:Method for the hydrolysis of quinolonecarboxylic esters
发明人:FEY PETER; BERWE MATHIAS; WIRTHS Joerg; WISCHNAT RALF; LONGERICH MARKUS; DIETZEL ANTJE
权利人:BAYER ANIMAL HEALTH GMBH
摘要:Quinolonecarboxylic esters of the general formula (II) are hydrolyzed to quinolonecarboxylic acids of the general formula (I):The method comprises the step A):A) reacting compounds of the formula (II) with a mixture comprising acetic acid, sulfuric acid and waterIn step A), ≥30 to ≤40 mol of acetic acid, ≥0.3 to ≤1 mol of sulfuric acid and ≥0.9 to ≤2.5 mol of water are used per mole of compounds of the formula (II). The method is particularly suitable for the synthesis of the intermediate (I) in the synthesis of pradofloxacin.

专利号:US-8093381-B2
优先权日:2007-05-24
标题:Method of synthesis of fluoroquinolones
发明人:BERTHON-CEDILLE LAURENCE; LEGUERN MARIE-EMMANUELLE; RENAUD GILLES; TOMBRET FRANCIS
权利人:BERTHON-CEDILLE LAURENCE; LEGUERN MARIE-EMMANUELLE; RENAUD GILLES; TOMBRET FRANCIS; BIOCODEX
摘要:The invention relates to a method of preparation of fluoroquinolones of formula (I) from compounds of formula (II): n nin which R 1 , R 2 , R 3 , R 4 , R 5 , R 6 , R 7 , and X are as defined in Claim 1.

专利号:US-2009054643-A1
优先权日:2007-05-24
标 题:Novel method of synthesis of fluoroquinolones

专利号:EP-2138490-B1
优先权日:2007-05-24
标题 :New method for synthesis of fluoroquinolones

专利号:CN-118894976-A
优先权日:2024-09-30
标题 :Synthesis method and application of zwitterionic covalent organic framework nano-sheet

专利号:CN-118894976-B
优先权日:2024-09-30
标题:Synthesis method and application of zwitterionic covalent organic framework nanosheets
常州航宇医药技术开发有限公司
⚠️ 未注册 · 未认证企业
⚠️ 该商家尚未完成注册及企业认证,请用户仔细辨别,谨慎交易。
数据来源于公开网络搜索,平台未作核实,请自行辨别。
🏢敬请 企业认领
🏬开设公司展台
📢获取免费会员权益
🎖️点亮专属注册企业标签
📇展现公司完整信息 样本查看立即注册认领 →
网址: http://www.czyys.com
电话: 86-519-88802789 13961196887👤
📞常州航宇医药技术开发有限公司 ⚠️参考联系方式

销售电话:86-519-88802789 13961196887
邮箱:sales@czyys.com
🆔 联系时候可告知是从"百琢研"平台获取的信息.
⚠️ 声明: 该企业未认证、未认领,请自行辨别信息的真实性和可靠性。咨询或交易时请注意风险评估与信息核实,百琢研不参与任何交易。企业认领注册入口→

⚠️ 未注册 · 未认证企业
注册入口 备注: 📌 数据来源说明:本展台内容基于各搜索引擎等公开数据整理,仅作展示用途。请用户自行辨别 ✉️ 若企业需抹除展台内容或有异议, 请通过页面底部联系方式告知我们,我们会尽快处理。
浙江京新药业股份有限公司
⚠️ 未注册 · 未认证企业
⚠️ 该商家尚未完成注册及企业认证,请用户仔细辨别,谨慎交易。
数据来源于公开网络搜索,平台未作核实,请自行辨别。
🏢敬请 企业认领
🏬开设公司展台
📢获取免费会员权益
🎖️点亮专属注册企业标签
📇展现公司完整信息 样本查看立即注册认领 →
网址: http://www.jingxinpharm.com
电话: 0575-86298608👤
📞浙江京新药业股份有限公司 ⚠️参考联系方式

销售电话:0575-86298608
邮箱:hyjmails85@tom.com
🆔 联系时候可告知是从"百琢研"平台获取的信息.
⚠️ 声明: 该企业未认证、未认领,请自行辨别信息的真实性和可靠性。咨询或交易时请注意风险评估与信息核实,百琢研不参与任何交易。企业认领注册入口→

⚠️ 未注册 · 未认证企业
注册入口 备注: 📌 数据来源说明:本展台内容基于各搜索引擎等公开数据整理,仅作展示用途。请用户自行辨别 ✉️ 若企业需抹除展台内容或有异议, 请通过页面底部联系方式告知我们,我们会尽快处理。
第 1 / 1 页
现货

供应商参考报价(招募中)

品牌试剂参考报价(招募中)

📌 第三方产品分析报告

✅ COA系统入驻 | 共享模式

主要参考文献


1: Kreizinger Z, Grózner D, Sulyok KM, Nilsson K, Hrivnák V, Benčina D, Gyuranecz M. Antibiotic susceptibility profiles of Mycoplasma synoviae strains originating from Central and Eastern Europe. BMC Vet Res. 2017 Nov 17;13(1):342. doi: 10.1186/s12917-017-1266-2.
2: Liang S, Lu L, Meng F. DOM-mediated membrane retention of fluoroquinolone as revealed by fluorescence quenching properties. Sci Rep. 2017 Jul 14;7(1):5372. doi: 10.1038/s41598-017-05635-z.
3: Rusch M, Spielmeyer A, Meißner J, Kietzmann M, Zorn H, Hamscher G. Efficient Reduction of Antibacterial Activity and Cytotoxicity of Fluoroquinolones by Fungal-Mediated N-Oxidation. J Agric Food Chem. 2017 Apr 19;65(15):3118-3126. doi: 10.1021/acs.jafc.7b01246. Epub 2017 Apr 10. doi: 10.1136/vr.103964. Epub 2017 Feb 17. doi: 10.1002/elps.201600475. Epub 2017 Mar 6. pii: e01756-16. doi: 10.1128/AAC.01756-16. Print 2017 Feb.

合成参考文献


参考文献:10.1080/19440049.2011.587028
摘要:Takeda N, Gotoh M, Matsuoka T. Rapid screening method for quinolone residues in livestock and fishery products using immobilised metal chelate affinity chromatographic clean-up and liquid chromatography-fluorescence detection. Food Addit Contam Part A Chem Anal Control Expo Risk Assess. 2011 Sep;28(9):1168–74. doi: 10.1080/19440049.2011.587028.
参考文献:10.4061/2011/263768
摘要:Weese JS, Blondeau JM, Boothe D, Breitschwerdt EB, Guardabassi L, Hillier A, Lloyd DH, Papich MG, Rankin SC, Turnidge JD, Sykes JE. Antimicrobial Use Guidelines for Treatment of Urinary Tract Disease in Dogs and Cats: Antimicrobial Guidelines Working Group of the International Society for Companion Animal Infectious Diseases. Veterinary Medicine International. 2011;2011():1–9. doi: 10.4061/2011/263768.
📝 需求与反馈
尽可能描述清楚需求与问题信息
×

通知